FDA 483 - PETNET Solutions, Inc. - March 02, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
During an inspection from February 24 to March 2, 2026, PETNET Solutions, Inc. in Atlanta, GA, a manufacturer of Positron Emission Tomography (PET) drugs, was cited for significant deficiencies. Observations included a lack of adequate procedures for equipment cleaning, maintenance, and environmental monitoring within Hot Cells, as well as inadequate production and process controls, specifically concerning aseptic techniques during PET drug preparation and dispensing. These issues indicate a failure to ensure the quality and purity of PET drugs.
ID · 156f7ec3-1ee7-411b-adc7-2a978930627d